Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.
Health
Rutgers Health researchers and others find hundreds of young patients receive potentially dangerous medication combinations, raising concerns about prescription practices.
Known risks from assisted reproductive technology and early placenta separation combine for a larger overall preterm delivery risk.
Rutgers Health researchers explain how to distinguish concerning rashes from less severe reactions.